La cadena de opciones muestra datos clave de las opciones de acciones de Wheaton Precious Metals a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Wheaton Precious Metals..

Wheaton Precious Metals (NYSE:WPM) Bolsa, Cadena de Opciones

Wheaton Precious Metals

Wheaton Precious Metals Corp is a precious metal streaming company. The company metal streaming company which generates its revenue primarily from the sale of precious metals (gold, silver and palladium) and cobalt. Its reportable segment includes: Gold, Silver, Palladium, Platinum, Cobalt, and Other.

Macro,View,Of,Stacks,Of,Gold,Bars

Long Ideas

Commodities

Forex

Markets

Trading Ideas

Agnico, Newmont y Wheaton lideran el repunte del oro, impulsadas por el dólar débil y el atractivo global del lingote como refugio.

Acciones de oro se disparan: Agnico, Newmont y Wheaton suben más del 50% en medio de caída del dólar

Wheaton Precious Metals Corp Common Shares (Canada)

Wheaton Precious Metals Corp

WESTERN PACIFIC MNRLS LTD by Western Pacific Minerals Ltd.

Western Pacific Minerals

WIIM

Core Scientific, Inc. - Class A Common Stock

CORZ

Core Scientific shares are trading lower following a merger announcement with CorWeave.

Halozyme Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HALO#NASDAQ">HALO</a>) has outperformed the market over the past 15 years by 2.0% on an annualized basis producing an average annual return of 14.27%. Currently, Halozyme Therapeutics has a market capitalization of $6.64 billion. 
Buying $1000 In HALO: If an investor had bought $1000 of HALO stock 15 years ago, it would be worth $7,847.10 today based on a price of $53.89 for HALO at the time of writing.
<h3>Halozyme Therapeutics's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751898613_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

HALO

Here's How Much You Would Have Made Owning Halozyme Therapeutics Stock In The Last 15 Years

Piper Sandler analyst Patrick Moley initiates coverage on Chime Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHYM#NASDAQ">CHYM</a>) with a Overweight rating and announces Price Target of $40.

Price Target

Initiation

Analyst Ratings

CHYM

Piper Sandler Initiates Coverage On Chime Financial with Overweight Rating, Announces Price Target of $40

William Blair analyst Louie DiPalma upgrades CACI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) from Market Perform to Outperform.

Upgrades

CACI

William Blair Upgrades CACI International to Outperform

William Blair analyst Jed Dorsheimer downgrades Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) from Outperform to Market Perform.

Downgrades

TSLA

William Blair Downgrades Tesla to Market Perform

Chime Financial Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHYM#NASDAQ">CHYM</a>) just vaulted to the <a href="https://www.benzinga.com/news/financing">sixth-largest debit card issuer </a>in the U.S., all without a single physical branch.
JPMorgan analyst Tien‑tsin Huang initiated coverage on the stock with an Overweight rating and a $40 price target for December 2026. That&#8217;s about 28% upside from the current $31.32 level.
<h2 class="wp-block-heading">The Fintech That Cracked The Code</h2>
Chime didn't just stumble into scale &#8211; it engineered it. With 8.6 million members &#8211; mostly everyday Americans earning under $100K &#8211; it built trust through a "low cost, no cost" ethos. 
More than two-thirds of members use Chime as their primary banking account. And because of convenient features like SpotMe overdraft protection, users saved over $2 billion in fees in 2024 alone, noted Huang.
Read Also: <a href="https://www.benzinga.com/analyst-stock-ratings/initiation/25/07/46272029/this-rockwell-automation-analyst-begins-coverage-on-a-bullish-note-here-are-top-4-initiations-for-monday">This Rockwell Automation Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Monday</a>
<h2 class="wp-block-heading">Spend First, Earn Later</h2>
Here's where the magic compounds: Huang highlighted that members swipe 50+ times per month, averaging $15K in annual spending &#8211; over four times what typical debit users spend. That non-discretionary spending means ~75% of Chime's revenue flows from merchant interchange fees, not high-risk lending. 
Think of it as transactional gold, not loan gamble.
<h2 class="wp-block-heading">Scale, Engagement, Product Velocity</h2>
Chime's "spend-first, permission-to-lend" model delivers two things: engagement and expansion. With ChimeCore, its proprietary platform, it can scale new fintech features rapidly. 
And now, by lowering barriers on its MyPay earned wage access, Huang said, the company is lowering user acquisition costs while boosting annual member revenue to around $442 &#8211; nearly double Chime's average ARPU.
<h2 class="wp-block-heading">Why $40 By 2026?</h2>
JPMorgan is applying a 9x multiple to projected 2027 transaction profits, a level that peers in fintech comfortably trade at. With 20%+ revenue CAGR and 10-point budget expansion in adjusted EBITDA margins, Chime looks like a bank &#8211; without the baggage.
Chime's mission isn't just marketing &#8211; it's a moat. It has cracked everyday banking for the underserved, built trust, and created a loyalty-driven revenue engine, says Huang.
And Wall Street is finally noticing: this non-bank could become one of the fintechs to watch.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46273662/no-plan-b-teslas-musk-premium-is-on-thin-ice">No Plan B &#8211; Tesla&#8217;s Musk Premium Is On Thin Ice</a></li>
</ul>
Image: Shutterstock

Analyst Color

Fintech news covering the emerging Financial Technology services sector

Fintech

Financing

Meet Chime: Sixth-Largest Debit Card Issuer—And It's Not Even A Bank

UBS analyst Amit Mehrotra initiates coverage on GE Vernova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) with a Buy rating and announces Price Target of $614.

UBS Initiates Coverage On GE Vernova with Buy Rating, Announces Price Target of $614

The Bank of New York Mellon Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BK#NYSE">BK</a>) will release earnings results for the second quarter, <a href="https://www.benzinga.com/quote/BK/earnings">before the opening bell on Tuesday, July 15.</a>
Analysts expect the New York-based company to report quarterly earnings at $1.75 per share, up from $1.51 per share in the year-ago period. Bank of New York Mellon projects to report quarterly revenue at $4.81 billion, compared to $4.6 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On July 1, BNY announced intention to increase quarterly common stock dividend by 13% to 53 cents per share.
Bank of New York Mellon shares gained 0.4% to close at $92.43 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/bk/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Evercore ISI Group analyst Glenn Schorr maintained an In-Line rating and raised the price target from $88 to $90 on July 2, 2025. This analyst has an accuracy rate of 71%.</li>
<li>Morgan Stanley analyst Betsy Graseck maintained an Overweight rating and increased the price target from $94 to $95 on June 3, 2025. This analyst has an accuracy rate of 61%.</li>
<li>Truist Securities analyst David Smith downgraded the stock from Buy to Hold and raised the price target from $87 to $97 on May 28, 2025. This analyst has an accuracy rate of 72%.</li>
<li>Citigroup analyst Keith Horowitz maintained a Neutral rating and increased the price target from $82 to $85 on March 24, 2025. This analyst has an accuracy rate of 77%.</li>
<li>RBC Capital analyst Gerard Cassidy reiterated a Sector Perform rating with a price target of $90 on March 17, 2025. This analyst has an accuracy rate of 77%.</li>
</ul>
Considering buying BK stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/bk/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="589" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07024434/image-55-1024x589.png" alt="" class="wp-image-974138" style="width:586px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07024434/image-55-1024x589.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07024434/image-55-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07024434/image-55-768x441.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/07024434/image-55.png 1117w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46243448/cramer-doesnt-recommend-titan-international-joby-aviation-soars-after-milestone-flight">Cramer Doesn&#8217;t Recommend Titan International, Joby Aviation Soars After Milestone Flight</a> </li>
</ul>
Photo via Shutterstock

Earnings

Bank of New York Mellon Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Roth Capital analyst Jeff Martin maintains Franklin Covey (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FC#NYSE">FC</a>) with a Buy and lowers the price target from $30 to $27.

Roth Capital Maintains Buy on Franklin Covey, Lowers Price Target to $27

Royal Gold, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGLD#NASDAQ">RGLD</a>) is making a decisive move to scale up in the precious metals streaming and royalty space through <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/n46270672/royal-gold-to-acquire-sandstorm-gold-royalties-and-horizon-copper-forming-large-scale-industry-lea" rel="noreferrer noopener">two simultaneous acquisitions</a>, a $3.5 billion all-share merger with Sandstorm Gold Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAND#NYSE">SAND</a>) and a $196 million cash deal for Horizon Copper Corp. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/HNCUF#OTC">HNCUF</a>).
Under the terms, Sandstorm shareholders will receive 0.0625 Royal Gold shares for each share held, reflecting a 21% premium to its 20-day average price.
The Horizon acquisition values each share at 2.00 Canadian dollars, representing an 85% premium over its recent average. These deals aim to create a dominant North American player with deep asset diversity and enhanced cash flow strength.
Also Read: <a target="_blank" href="https://www.benzinga.com/m-a/25/07/46191888/chinas-largest-gold-mine-expands-in-central-asia-with-1-2-billion-acquisition" rel="noreferrer noopener">China&#8217;s Largest Gold Miner Expands In Central Asia With $1.2 Billion Acquisition</a>
When finalized, the combined portfolio will comprise 393 streams and royalties, largely focused in the Americas, with 80 cash-flowing assets and 47 in development. Approximately 87% of its revenue will stem from precious metals, with gold alone contributing about 75% in 2025. No single asset will make up more than 13% of net asset value, significantly lowering risk from asset concentration.
Royal Gold will maintain its name post-merger, while Sandstorm investors will hold around 23% of the enlarged entity. Sandstorm&#8217;s CEO, Nolan Watson, called the agreement a &#8220;milestone&#8221; and noted the merger allows investors to participate in a stronger, more liquid company with long-term upside.
Horizon CEO Erfan Kazemi emphasized the value unlocked for shareholders as Horizon integrates its copper-heavy portfolio into a bigger precious metals platform.
The transaction adds key assets such as Mount Milligan in Canada, Pueblo Viejo in the Dominican Republic, and MARA in Argentina. Projects in Chile, South Africa, Türkiye, and Botswana round out a global footprint focused in mining-friendly regions. Development-stage investments like Hod Maden, Platreef, and Antamina are also expected to drive future organic growth.
Boards and special committees at all three companies have endorsed the deals. Final approval depends on shareholder votes, court proceedings, and regulatory sign-offs, including antitrust reviews in Canada and South Africa. Completion is anticipated in the fourth quarter of 2025, after which Sandstorm and Horizon shares will be delisted.
Royal Gold held <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45265814/royal-gold-reports-record-earnings-for-the-first-quarter-and-a-strong-start-to-2025" rel="noreferrer noopener">$240.76 million</a> in cash and cash equivalents as of March 31, 2025.
Related ETFs: VanEck Gold Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDX#NYSE">GDX</a>), iShares MSCI Global Metals &amp; Mining Producers ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PICK#NYSE">PICK</a>).
Price Action: SAND shares are trading higher by 5.30% to $10.14, and RGLD shares are trading lower by 8.36% to $164.80 at the last check Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/forex/25/07/46272823/as-us-dollar-sinks-top-economist-warns-10-slide-could-spark-new-inflation-spike" target="_blank" rel="noreferrer noopener">As US Dollar Sinks, Top Economist Warns 10% Slide Could Spark New Inflation Spike</a></li>
</ul>
Photo via Shutterstock

Market Vectors ETF Trust Market Vectors Gold Miners

HNCUF

PICK

RGLD

SAND

Royal Gold Acquires Sandstorm And Horizon In Bold Expansion Move

ARTL

Artelo Biosciences Shares Halted On Circuit Breaker To The Downside, Stock Now Up 78.9%

Truist Securities analyst William Stein maintains MACOM Technology Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSI#NASDAQ">MTSI</a>) with a Buy and raises the price target from $136 to $154.

MTSI

Truist Securities Maintains Buy on MACOM Technology Solns, Raises Price Target to $154

Truist Securities analyst William Stein maintains TTM Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTMI#NASDAQ">TTMI</a>) with a Buy and raises the price target from $41 to $48.

TTMI

Truist Securities Maintains Buy on TTM Technologies, Raises Price Target to $48

EHGO

EHGO stock has given up its prior gain. Eshallgo shares were trading higher after the company announced it secured an exclusive partnership with a top Chinese printer maker.

MRNO

MRNO stock has given up its prior gain. Murano Global Investments shares were trading higher after the company announced it entered into a $500 million equity purchase agreement with Yorkville to enhance its Bitcoin treasury strategy.

U.S. stocks were lower, with the Dow Jones index falling over 100 points on Monday.
Shares of KalVista Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALV#NASDAQ">KALV</a>) rose sharply during Monday's session after the company announced it won<a href="https://www.benzinga.com/news/fda/25/07/46271482/fda-approves-kalvistas-ekterly-as-first-oral-on-demand-treatment-for-rare-swelling-disease"> FDA approval for EKTERLY</a>.
The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals' Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.
KalVista Pharmaceuticals shares jumped 17% to $14.02 on Monday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>Cogent Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COGT#NASDAQ">COGT</a>) surged 26.6% to $9.60 after the company announced topline results from Part 2 of the SUMMIT trial of bezuclastinib for non-advanced systemic mastocytosis, showing clinically meaningful and statistically significant improvements across the primary and all key secondary endpoints.</li>
<li>Prime Medicine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRME#NASDAQ">PRME</a>) rose 26.2% to $3.9046.</li>
<li>So-Young International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SY#NASDAQ">SY</a>) shares jumped 26.2% to $4.10.</li>
<li>Northern Dynasty Minerals Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NAK#NYSE">NAK</a>) gained 24% to $1.7352.</li>
<li>Bit Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTBT#NASDAQ">BTBT</a>) rose 22.9% to $3.6150. Bit Digital raised $172 million in public offering, converted treasury by selling 280 Bitcoin to acquire 100,603 ETH.</li>
<li>WNS (Holdings) Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WNS#NYSE">WNS</a>) rose 14.2% to $74.63 after announcing that Capgemini will acquire the company for $3.3 billion.</li>
<li>SharpLink Gaming, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) gained 12.8% to $14.28.</li>
<li>Amber International Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMBR#NASDAQ">AMBR</a>) gained 12.5% to $9.68. Amber International filed for mixed shelf offering of up to $500 million.</li>
<li>Next Technology Holding Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXTT#NASDAQ">NXTT</a>) gained 7.5% to $2.7097.</li>
<li>Bilibili Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BILI#NASDAQ">BILI</a>) rose 6% to $22.12.</li>
<li>Frontline plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRO#NYSE">FRO</a>) gained 5.7% to $18.47.</li>
<li>CoreCivic, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CXW#NYSE">CXW</a>) rose 5.2% to $22.79 in reaction to ICE funding in President Trump&#8217;s spending bill.</li>
<li>Yum China Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>) gained 5.1% to $48.10.</li>
<li>Baidu, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) rose 4.5% to $90.13.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/07/46270970/jpmorgan-gears-up-for-q2-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts">JPMorgan Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>
Photo via Shutterstock

Intraday Update

Movers

AMBR

BIDU

BILI

BTBT

COGT

KALV

Next Technology Holding Inc. - Ordinary Shares

NXTT

PRME

SBET

YUMC

KalVista Pharmaceuticals, Cogent Biosciences, WNS And Other Big Stocks Moving Higher On Monday

UBS analyst William Appicelli upgrades Public Service Enterprise (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEG#NYSE">PEG</a>) from Neutral to Buy and raises the price target from $86 to $97.

UBS Upgrades Public Service Enterprise to Buy, Raises Price Target to $97

Truist Securities analyst Arren Cyganovich initiates coverage on Blue Owl Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OTF#NYSE">OTF</a>) with a Buy rating and announces Price Target of $17.

Truist Securities Initiates Coverage On Blue Owl Technology with Buy Rating, Announces Price Target of $17

Enables Web 3.0 Stablecoin Delivery via Broadcast to Mobile Smartphone Users Worldwide
DataVault AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DVLT#NASDAQ">DVLT</a>), a leader in AI-driven blockchain and data monetization, today announced the acquisition of SyncIN technology from Turner Global Media, LLC (TGM). This innovative platform uses inaudible tone mobile quick response codes embedded in broadcasts—spanning TV, radio, and retail environments—to connect consumers directly to content and enable seamless stable coin transactions via Web 3.0 Crypto Anchors. Targeting the $700 billion advertising market, DVLT leverages its NYIAX partnership and TGM's extensive ad inventory for high-margin, royalty-based revenue.
Bridging Broadcasts and Blockchain
SyncIN's inaudible audio technology embeds imperceptible tones within broadcasts, detected effortlessly by smartphones. These tones link consumers to advertisements or trigger instant stable coin transactions—secured by Web 3.0 Crypto Anchors—for decentralized purchases. From iHeartRadio ads to in-store promotions at Walmart, SyncIN transforms passive listening into blockchain-verified commerce. With stable coins gaining global traction and the U.S. Congress nearing passage of the Genius Act and Stable Coin Act, DVLT is well-positioned for growth.
"This acquisition propels Datavault AI into the future of advertising and e-commerce," said Nathaniel T. Bradley, CEO of DataVault AI. "SyncIN's inaudible tones unlock a Web 3.0 economy with real-time stable coin transactions. We're targeting 10 to 15 licensing deals in 2025 to drive shareholder value and establish category leadership."
SyncIN and Adio technologies scale across:
<ul>
<li>TV &amp; Radio: Reaches 90%+ of U.S. households and 240 million monthly listeners via partners like Procter &amp; Gamble and PepsiCo.</li>
<li>Retail: Engages 140 million weekly shoppers at Walmart, Kroger, and CVS.</li>
<li>Hospitality: Connects with 140 million annual visitors at MGM, Hilton, and Westgate Resorts.</li>
</ul>
With billions of annual ad impressions through Turner Global Media Networks and affiliates, Datavault turns broadcasts into direct revenue channels, secured by blockchain.
Financial Strength
<ul>
<li>Revenue Targets 10–15 high-margin licensing deals in 2025, supporting a $40–50 million revenue goal for 2026.</li>
<li>Patent Powerhouse: Nine new patent allowances (June 23, 2025) and SyncIN's IP, backed by Fish &amp; Richardson and Greenberg Traurig, strengthen DVLT's edge.</li>
</ul>
Regulatory Leadership
With the Genius Act and Stable Coin Act nearing passage, Datavault's stable coin integration ensures compliance while pioneering decentralized transactions, positioning it to lead as stable coins shape digital finance.

DVLT

DataVault AI Acquires SyncIN Tech To Enable Web 3.0 Stablecoin Transactions Via Inaudible Broadcast Tones, Financial Terms Of Transaction Not Disclosed; Targeting $40M-$50M Revenue Goal For 2026

Raymond James analyst David Long downgrades Wells Fargo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) from Strong Buy to Market Perform.

Comments

Wheaton Precious Metals

Wheaton Precious Metals (WPM) Opciones

Wheaton Precious Metals (NYSE:WPM) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL